CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
For full access to this article login to GEN Select now.
ChromaTan Purifies against the Current
New Single-Use, Column-Free Chromatography Method Raises Efficiency, Lowers Costs
- ChromaTan’s continuous and single-use chromatography system breaks the bottlenecks inherent in traditional column chromatography, enabling cost-effective, steady-state operation. This system, Countercurrent Tangential Chromatography (CTC) is designed to accommodate recent advances in bioprocessing and cell culture technology. “Improvements in cell culture and bioreactor design during the past 15 years ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.